Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.
PURPOSE: Aldose reductase (AR) has been a drug target because of its involvement in the development of secondary complications of diabetes including cataract. We have previously reported that the aqueous extract of Emblica officinalis and its constituent ..... Read More